-
1دورية أكاديمية
المؤلفون: Hendrikse, C.S.E., Theelen, P.M.M., van der Ploeg, P., Westgeest, H.M., Boere, I.A., Thijs, A.M.J., Ottevanger, P.B., van de Stolpe, A., Lambrechts, S., Bekkers, R.L.M., Piek, J.M.J.
المصدر: Hendrikse , C S E , Theelen , P M M , van der Ploeg , P , Westgeest , H M , Boere , I A , Thijs , A M J , Ottevanger , P B , van de Stolpe , A , Lambrechts , S , Bekkers , R L M & Piek , J M J 2023 , ' The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis ' , Gynecologic Oncology , vol. 171 , no. 1 , pp. 83-94 . https://doi.org/10.1016/j.ygyno.2023.01.038Test
مصطلحات موضوعية: MAPK pathway, MAPK inhibitors, Targeted therapy, Signal transduction pathway, Ovarian cancer, Clinical benefit, EPITHELIAL OVARIAN, PHASE-II, DOSE-ESCALATION, MEK INHIBITOR, DOUBLE-BLIND, HIGH-GRADE, COMBINATION, KINASE, BRAF, TRAMETINIB
العلاقة: https://cris.maastrichtuniversity.nl/en/publications/517abf66-a989-4315-913e-263e0f0235dfTest
الإتاحة: https://doi.org/10.1016/j.ygyno.2023.01.038Test
https://cris.maastrichtuniversity.nl/en/publications/517abf66-a989-4315-913e-263e0f0235dfTest -
2دورية أكاديمية
المؤلفون: Ploeg, P. van der, Hendrikse, C.S.E., Thijs, A.M.J., Westgeest, H.M., Smedts, H.P.M., Vos, M.C., Jalving, M., Lok, C. A. R., Boere, I.A., Ham, M.A.P.C. van, Ottevanger, N., Westermann, A.M., Mom, C.H., Lalisang, R.I., Lambrechts, S., Bekkers, R.L.M., Piek, J.M.J.
المصدر: Heliyon, 10, 1, pp. e23170
مصطلحات موضوعية: All institutes and research themes of the Radboud University Medical Center, Radboudumc 17: Women's cancers Gynaecology, Radboudumc 17: Women's cancers Medical Oncology
العلاقة: https://repository.ubn.ru.nl//bitstream/handle/2066/302033/302033.pdfTest; https://repository.ubn.ru.nl/handle/2066/302033Test
الإتاحة: https://doi.org/10.1016/j.heliyon.2023.e23170Test
https://repository.ubn.ru.nl//bitstream/handle/2066/302033/302033.pdfTest
https://repository.ubn.ru.nl/handle/2066/302033Test -
3دورية أكاديمية
المؤلفون: Kos, M., Buffart, L.M., Westgeest, H.M., de Groot, J.W.B., Boers-Sonderen, M., van Laarhoven, H.W.M., van Oijen, M.
المصدر: Annals of Oncology ; volume 33, page S948 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.999Test
https://api.elsevier.com/content/article/PII:S0923753422028502?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422028502?httpAccept=text/plainTest -
4دورية أكاديمية
المؤلفون: de Joode, K., Suijkerbuijk, K.P.M., de Groot, J.W.B., Van der Veldt, A.A.M., Westgeest, H.M., de Wijn, R., Hurkmans, D.P., van den Heuvel, D.M.A., Schmidt, K., van Doorn, T., Pinedo, H.M., Groten, J.P., Verdegaal, E.M.E., van der Burg, S.H., Aerts, J.G., Debets, R., Kapiteijn, E., Mathijssen, R.H.
المصدر: Annals of Oncology ; volume 33, page S943 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.986Test
https://api.elsevier.com/content/article/PII:S092375342202837X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342202837X?httpAccept=text/plainTest -
5دورية أكاديمية
المؤلفون: van der Ploeg, P., Uittenboogaard, A., Thijs, A.M.J., Westgeest, H.M., Boere, I.A., Lambrechts, S., van de Stolpe, A., Bekkers, R.L.M., Piek, J.M.J.
المصدر: van der Ploeg , P , Uittenboogaard , A , Thijs , A M J , Westgeest , H M , Boere , I A , Lambrechts , S , van de Stolpe , A , Bekkers , R L M & Piek , J M J 2021 , ' The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis ' , Gynecologic Oncology , vol. 163 , no. 2 , pp. 433-444 . https://doi.org/10.1016/j.ygyno.2021.07.008Test
مصطلحات موضوعية: Ovarian cancer, Phosphatidylinositol-3-kinase, Akt, Mammalian target of rapamycin, Signal transduction pathway, Targeted therapy, ADVANCED SOLID TUMORS, PHASE-I, PI3K PATHWAY, EPITHELIAL OVARIAN, DOSE-ESCALATION, 1ST-IN-HUMAN, TRIAL, MULTICENTER, MTOR, TEMSIROLIMUS
الإتاحة: https://doi.org/10.1016/j.ygyno.2021.07.008Test
https://cris.maastrichtuniversity.nl/en/publications/1cb433d6-e52a-4ee4-823d-8a951ec93922Test -
6دورية أكاديمية
المؤلفون: de Meza, M.M., Ismail, R.K., Rauwerdink, D., van Not, O.J., van Breeschoten, J., Blokx, W.A.M., de Boer, A., van Dartel, M., Hilarius, D.L., Ellebaek, E., Bonenkamp, H.J., Blank, C.U., Aarts, M.J.B., van Akkooi, A.C.J., van den Berkmortel, F.W.P.J., Boers-Sonderen, M.J., de Groot, J.W.B., Haanen, J.B., Hospers, G.A.P., Kapiteijn, E.W., Piersma, D., van Rijn, R.S., van der Veldt, A.A.M., Vreugdenhil, A., Westgeest, H.M., van den Eertwegh, A.J.M., Suijkerbuijk, K.P.M., Wouters, M.W.J.M.
المصدر: de Meza , M M , Ismail , R K , Rauwerdink , D , van Not , O J , van Breeschoten , J , Blokx , W A M , de Boer , A , van Dartel , M , Hilarius , D L , Ellebaek , E , Bonenkamp , H J , Blank , C U , Aarts , M J B , van Akkooi , A C J , van den Berkmortel , F W P J , Boers-Sonderen , M J , de Groot , J W B , Haanen , J B ....
مصطلحات موضوعية: Melanoma, Immune checkpoint inhibitors, Immunotherapy, Nivolumab, Pembrolizumab, Survival rate, Skin neoplasms, Data management, Registries, Quality of health care, METASTATIC MELANOMA, STAGE-III, IPILIMUMAB
الإتاحة: https://doi.org/10.1016/j.ejca.2021.08.044Test
https://cris.maastrichtuniversity.nl/en/publications/1768887f-b50e-4ae8-84eb-fdc4ca69a917Test -
7دورية أكاديمية
المؤلفون: Joode, K.D., van de Geer, W.S., van Leenders, G.J.L.H., Hamberg, P., Westgeest, H.M., Beeker, A., Oosting, S.F., van Rooijen, J.M., Beerepoot, L.V., Labots, M., Mathijssen, R.H., Lolkema, M.P., Cuppen, E., Sleijfer, S., van de Werken, H.J.G., Van der Veldt, A.A.M.
المساهمون: Boehringer Ingelheim, Novartis, Roche
المصدر: Annals of Oncology ; volume 32, page S1386 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2021.10.047Test
https://api.elsevier.com/content/article/PII:S092375342104583X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342104583X?httpAccept=text/plainTest -
8دورية أكاديمية
المؤلفون: De Meza, M.M., Ismail, R., Blokx, W.A.M., Blank, C.U., Van den Eertwegh, A.J.M., Aarts, M., van Akkooi, A.C.J., Van den Berkmortel, F., Boers-Sonderen, M., Kapiteijn, E., de Groot, J.W.B., Haanen, J.B.A.G., Hospers, G.A., Piersma, D., van Rijn, R.S., Van der Veldt, A.A.M., Vreugdenhil, G., Westgeest, H.M., Suijkerbuijk, K., Wouters, M.W.J.M.
المساهمون: GlaxoSmithKline, Roche, Bristol-Myers Squibb, AstraZeneca, Meso Scale Diagnostics
المصدر: Annals of Oncology ; volume 32, page S888-S889 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.1455Test
https://api.elsevier.com/content/article/PII:S092375342103684X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342103684X?httpAccept=text/plainTest -
9دورية أكاديمية
المؤلفون: Franken, M.G., Leeneman, B., Aarts, M.J.B., van Akkooi, A.C.J., van den Berkmortel, F.W.P.J., Boers-Sonderen, M.J., van den Eertwegh, A.J.M., de Groot, J.W.B., Hospers, G.A.P., Kapiteijn, E., Piersma, D., van Rijn, R.S., Suijkerbuijk, K.P.M., van der Veldt, A.A.M., Westgeest, H.M., Wouters, M.W.J.M., Haanen, J.B.A.G., Uyl-de Groot, C.A.
المصدر: ESMO Open ; volume 6, issue 6, page 100320 ; ISSN 2059-7029
الإتاحة: https://doi.org/10.1016/j.esmoop.2021.100320Test
https://api.elsevier.com/content/article/PII:S2059702921002829?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2059702921002829?httpAccept=text/plainTest -
10دورية أكاديمية
المؤلفون: Slootbeek, P.H.J. (Peter), Duizer, M.L. (Marleen), Doelen, M.J. (Maarten), Kloots, I.S.H. (Iris), Kuppen, M.C.P. (Malou), Westgeest, H.M. (Hans), Uyl-de Groot, C.A. (Carin), Pamidimarri Naga, S. (Samhita), Ligtenberg, M.J. (Marjolijn), Oort, I.M. (Inge) van, Gerritsen, W.R. (Winald), Schalken, J.A. (Jack), L.I. Kroeze (Leonie), Bloemendal, H.J. (Haiko), Mehra, N. (Niven)
المصدر: International Journal of Cancer vol. 148 no. 2, pp. 385-395
مصطلحات موضوعية: platinum first (n = 4), responded to both agents. We confirm that BRCA2 inactivation is associated with meaningful responses to carboplatin, suggesting a role for both PARPi and platinum-based chemotherapy in preselected mCRPC patients
وصف الملف: application/pdf
العلاقة: http://repub.eur.nl/pub/134767Test; urn:hdl:1765/134767
